Disabled-1 is a large common fragile site gene, inactivated in multiple cancers
- PMID: 18008369
- DOI: 10.1002/gcc.20519
Disabled-1 is a large common fragile site gene, inactivated in multiple cancers
Abstract
Common fragile sites (CFS) are large, genomically unstable regions, which are hot-spots for deletions and other alterations, especially in cancer cells. Several have been shown to contain genes that span large genomic regions, such as FHIT (1.5 Mb), WWOX (1.0 Mb), GRID2 (1.36 Mb), PARK2 (1.3 Mb), and RORA (730 kb). These genes are frequently inactivated in multiple different cancers, and FHIT and WWOX are shown to function as tumor suppressors. The disabled-1 gene (DAB1) is one of the human homologs of the Drosophila disabled locus, which in mammals is involved in neuronal migration and lamination in the developing cerebral cortex. Mice DAB1 inactivation results in the neurological mutant Scrambler, having similarities to mice with the inactivation of PARK2 (Quaker), GRID2 (Lurcher), and RORA (Staggerer). We were interested in whether DAB1 was another large CFS gene that could have cancer development importance. We demonstrated here that the human DAB1 gene (spanning 1.25 Mb) mapped within FRA1B CFS region on chromosomal band 1p32.2. Real-time RT-PCR analysis revealed that the expression level of DAB1 was decreased in many human cancer samples, including primary tumor tissues and cancer-derived cell lines, from several different cancers, especially in brain and endometrial cancer. Additionally, the introduction of an over-expression DAB1 plasmid into two different cell lines, having insignificant endogenous DAB1 expression, resulted in decreased cell growth. In summary, DAB1 is another gene that resides within an unstable CFS region and might play a role in human tumorigenesis. These data may provide further linkage between neurological development and cancer.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Common fragile sites, extremely large genes, neural development and cancer.Cancer Lett. 2006 Jan 28;232(1):48-57. doi: 10.1016/j.canlet.2005.06.049. Epub 2005 Oct 10. Cancer Lett. 2006. PMID: 16221525 Review.
-
Non-random inactivation of large common fragile site genes in different cancers.Cytogenet Genome Res. 2007;118(2-4):260-9. doi: 10.1159/000108309. Cytogenet Genome Res. 2007. PMID: 18000379 Review.
-
DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors.Cytogenet Genome Res. 2007;119(3-4):196-203. doi: 10.1159/000112061. Epub 2008 Feb 1. Cytogenet Genome Res. 2007. PMID: 18253029
-
RORA, a large common fragile site gene, is involved in cellular stress response.Oncogene. 2006 May 11;25(20):2901-8. doi: 10.1038/sj.onc.1209314. Oncogene. 2006. PMID: 16462772
-
Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.Cancer Res. 2002 Jun 15;62(12):3477-84. Cancer Res. 2002. PMID: 12067991
Cited by
-
Impaired Replication Timing Promotes Tissue-Specific Expression of Common Fragile Sites.Genes (Basel). 2020 Mar 19;11(3):326. doi: 10.3390/genes11030326. Genes (Basel). 2020. PMID: 32204553 Free PMC article.
-
Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes.Cell Mol Life Sci. 2014 Dec;71(23):4561-75. doi: 10.1007/s00018-014-1723-z. Epub 2014 Sep 18. Cell Mol Life Sci. 2014. PMID: 25231336 Free PMC article. Review.
-
A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia.Haematologica. 2019 Apr;104(4):717-728. doi: 10.3324/haematol.2018.198267. Epub 2018 Nov 8. Haematologica. 2019. PMID: 30409797 Free PMC article.
-
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.J Med Genet. 2009 Jun;46(6):375-81. doi: 10.1136/jmg.2008.063917. Epub 2009 Apr 6. J Med Genet. 2009. PMID: 19351622 Free PMC article.
-
Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.Int J Mol Sci. 2024 Mar 20;25(6):3507. doi: 10.3390/ijms25063507. Int J Mol Sci. 2024. PMID: 38542478 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous